Contact dermatitis from tromantadine hydrochloride.

Area of Science:

• Dermatology
• Pharmacology
• Clinical Medicine

Background:

• Topical medications are frequently used for various dermatological conditions.
• Assessing the safety and adverse effects of topical treatments is crucial for patient care.
• Tromantadine hydrochloride is a topical antiviral agent.

Purpose of the Study:

• To evaluate the incidence of local irritation associated with 1% tromantadine hydrochloride ointment.
• To determine the proportion of irritation cases attributable to contact allergy.

Main Methods:

• A cohort of 240 patients received treatment with 1% tromantadine hydrochloride ointment.
• Local irritation was monitored in all treated patients.
• Patch testing was performed on patients experiencing local irritation to identify allergic contact dermatitis.

Main Results:

• A total of 20 out of 240 patients (8.3%) exhibited local irritation.
• Of the 20 patients with irritation, 12 (60%) were confirmed to have contact allergy via patch testing.
• This indicates that a significant portion of the observed irritation was allergic in nature.

Conclusions:

• 1% tromantadine hydrochloride ointment can cause local irritation in a subset of patients.
• Contact allergy is a notable cause of tromantadine hydrochloride-induced local irritation.
• Further investigation into the allergenic potential and risk management strategies for this topical agent is warranted.